TITLE

The usefulness of competitive PCR: airway gene expression of IL-5, IL-4, IL-4, IL-4δ2, IL-2, and IFNγ in asthma

AUTHOR(S)
Glare, E. M.; Divjak, M.; Bailey, M. J.; Walters, E. H.
PUB. DATE
July 2001
SOURCE
Thorax;Jul2001, Vol. 56 Issue 7, p541
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background--Asthma has been described as an eosinophilic bronchitis driven by interleukin (IL)-4 and IL-5. The quantification of cytokine mRNA levels in airway samples has been confounded by housekeeping gene expression which differs between and within asthmatics and controls. Methods--The usefulness of cometitive reverse transcriptase-polymerase chain reaction (RT-PCR) that is indepedent of housekeeping gene expression for quantitating the mRNA for interferon (IFN)Y, IL-2, IL-5, IL-4 and its receptor antagonist encoding splicing variant IL-482 was determined in a cross sectional study of 45 normal control subjects and 111 with asthma. Result-Atopic controls and atopic asthmatic subject expressed more IL-5 than non-atopic controls (p<0.02) in bronchoalveolar specimens. IL-5 mRNA expression in BAL cells from asthmatic subjects using inhaled corticosteroids (ICS) was significantly lower than those not receiving ICS (p=0.04). IL-2 mRNA levels differed with steroid use in biopsy specimens but not in BAL cells. IFNy, IL-4, and IL-482 mRNA levels did not differ between any groups and were not differ between any groups and were not affected by steroid use. IL-4 and IL-482 mRNA levels were positively correlated (p<0.0001), suggesting coordinated transcription. Conclusions--While the signal differentiation of competitive PCR in asthma may rival that of in situ hybridisation and immunohistochemistry, the method is expensive and wasteful of material.
ACCESSION #
12915355

 

Related Articles

  • IL-9 Induces CCL11 Expression via STAT3 Signalling in Human Airway Smooth Muscle Cells. Yamasaki, Akira; Saleh, Ali; Koussih, Latifa; Muro, Shigeo; Halayko, Andrew J.; Gounni, Abdelilah S. // PLoS ONE;2010, Vol. 5 Issue 2, p1 

    Background: Previous findings support the concept that IL-9 may play a significant role in mediating both pro-inflammatory and changes in airway responsiveness that characterizes the atopic asthmatic state. We previously demonstrated that human airway smooth muscle (ASM) cells express a...

  • Upregulation of ADAM8 in the Airways of Mice with Allergic Bronchial Asthma. Chiba, Yoshihiko; Onoda, Satoshi; Hattori, Yoshiyuki; Maitani, Yoshie; Sakai, Hiroyasu; Misawa, Miwa // Lung;May/Jun2009, Vol. 187 Issue 3, p179 

    Recent microarray analyses revealed that a disintegrin and metalloproteinase (ADAM) 8 (ADAM8; also called CD156) is one of the asthma candidate genes. However, the function of ADAM8 and its localization in the airways are still poorly understood. In the present study, the changes in the...

  • Increased Il-4 Mrna expression and poly-aromatic hydrocarbon concentrations from children with asthma. Al-Daghri, Nasser M.; Abd-Alrahman, Sherif; Draz, Hossam; Alkharfy, Khalid; Khader Mohammed, Abdul; Clerici, Mario S.; Alokail, Majed S. // BMC Pediatrics;2014, Vol. 14 Issue 1, p1 

    Background Asthma is the most common chronic childhood disease. Imbalance of cytokines released from T helper cells and environmental factors, such as exposure to poly-aromatic hydrocarbon (PAH), play pivotal roles in the pathogenesis of asthma. The aim of this study was to compare the mRNA...

  • A functional variant in IL12B promoter modulates its expression and associates with increased risk of allergic asthma. Xu, Z; Pei, L; Zhang, F; Hu, X; Gui, Y; Wang, L; Wu, B // Genes & Immunity;Jun2013, Vol. 14 Issue 4, p238 

    The interleukin-12B (IL12B) gene encodes the p40 chain of IL-12, a pro-inflammatory cytokine that antagonizes Th2 phenotype and, hence, may have a critical role in the pathogenesis of allergic asthma. In this report, we describe the identification of a novel IL12B promoter polymorphism (T-to-A...

  • IL-1 Receptor antagonist as a positional candidate gene in a murine model of allergic asthma. Ramadas, Ravisankar A.; Li, Xingnan; Shubitowski, Dennis M.; Samineni, Sridhar; Wills-Karp, Marsha; Ewart, Susan L. // Immunogenetics;Oct2006, Vol. 58 Issue 10, p851 

    Interleukin-1 receptor antagonist (IL-1ra) is an inhibitor of the proinflammatory IL-1. The IL-1ra gene ( Il1rn) maps near the allergen-induced bronchial hyper-responsiveness-1 locus, Abhr1, which we previously mapped to murine chromosome 2 using A/J (asthma susceptible) and C3H/HeJ (asthma...

  • Regulation of IL-9 expression by IL-25 signaling. Angkasekwinai, Pornpimon; Seon Hee Chang; Thapa, Manoj; Watarai, Hiroshi; Chen Dong // Nature Immunology;Mar2010, Vol. 11 Issue 3, p250 

    The physiological regulation of the expression of interleukin (IL)-9, a cytokine traditionally regarded as being TH2 associated, remains unclear. Here, we show that IL-9-expressing T cells generated in vitro in the presence of transforming growth factor-β and IL-4 express high levels of mRNA...

  • Interleukin-9 Receptor Expression in Asthmatic Airways In Vivo. Bhathena, P. R.; Comhair, S. A. A.; Holroyd, K. J.; Erzurum, S. C. // Lung;2000, Vol. 178 Issue 3, p149 

    Abstract. Inflammation of the airway wall is a defining feature in asthma and is likely the cause of the hyperreactivity and variable airflow limitation found in asthma. Immune response biased toward production of Th2 cytokines has been proposed as a mechanism in the pathogenesis of airway...

  • Evaluation of airway inflammation by quantitative Th1 /Th2 cytokine mRNA measurement in sputum of asthma patients. Truyen, E.; Coteur, I.; Dilissen, E.; Overbergh, I.; Dupont, L. J.; Ceuppens, J. L.; Bullens, D. M. A. // Thorax;Mar2006, Vol. 61 Issue 3, p202 

    Background: Asthma is a chronic inflammatory disorder of the airways driven by I cell activation. Th2 cells and their cytokines are thought to play a role in the pathophysiology of allergic as well as non-allergic asthma. Methods: Airway cells were obtained by sputum induction from 15 healthy...

  • Increased IL-10 mRNA and IL-23 mRNA expression in mulliple sclerosis: interferon-β treatment Increases IL-10 mRNA expression while reducing IL-23 mRNA expression. Krakauer, M.; Sorensen, P.; Khademi, M.; Olsson, T.; Sellebjerg, F. // Multiple Sclerosis (13524585);Jun2008, Vol. 14 Issue 5, p622 

    Background Interferon (IFN)-β therapy in multiple sclerosis (MS) has been suggested to promote a deviation from T lymphocyte production of pathogenic Th1 cytokines to less detrimental Th2 cytokines, but this is still controversial. We studied patterns of in vivo blood mononuclear cell (MNC)...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics